These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 1034084)

  • 21. Apoptosis: its pathophysiology and monitoring. The role of apoptosis in the radioiodine therapy of hyperthyroidism.
    Sopotyk AJ; Rogowski F; Parfieńczyk A
    Nucl Med Rev Cent East Eur; 2004; 7(1):53-8. PubMed ID: 15318312
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Incidence of hypothyroidism occurring long after iodine-131 therapy for hyperthyroidism.
    Holm LE; Lundell G; Israelsson A; Dahlqvist I
    J Nucl Med; 1982 Feb; 23(2):103-7. PubMed ID: 7057248
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The changes in the thyroid gland after irradiation with 131I or partial thyroidectomy for thyrotoxicosis.
    Kennedy JS; Thomson JA
    J Pathol; 1974 Feb; 112(2):65-81. PubMed ID: 4834051
    [No Abstract]   [Full Text] [Related]  

  • 24. Estimation of I131 doses absorbed by the thyroid in the period from May to June 1986.
    Chaś J; Bałtrukiewicz Z
    Acta Physiol Pol; 1987; 38(4):367-70. PubMed ID: 3452972
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Studies on 131-I treatment of hyperthyroidism. 3. Ultrastructural alteration of the thyroid before and after 131-I treatment].
    Konishi J
    Naika Hokan; 1970 Nov; 17(11):385-401. PubMed ID: 5530464
    [No Abstract]   [Full Text] [Related]  

  • 26. Laryngeal malignancy following iodine-125 therapy for thyrotoxicosis.
    McKillop JH; Doig JA; Kennedy JS; Thomson JA; Greig WR
    Lancet; 1978 Dec; 2(8101):1177-9. PubMed ID: 82143
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Treatment of Basedow hyperthyroidism by protracted doses of radioactive iodine].
    Reboul J; Caille JM; Bellet M; Tessier JP
    Sem Hop; 1969 Jun; 45(27):1884-94. PubMed ID: 4308228
    [No Abstract]   [Full Text] [Related]  

  • 28. Relationship between orally administered dose, surface emission rate for gamma radiation, and urine radioactivity in radioiodine-treated hyperthyroid cats.
    Feeney DA; Jessen CR; Weichselbaum RC; Cronk DE; Anderson KL
    Am J Vet Res; 2003 Oct; 64(10):1242-7. PubMed ID: 14596461
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Treatment of thyrotoxicosis with radioactive iodine (131I). Evaluation of a method].
    Rønnov-Jessen AD; Grønbaek P
    Ugeskr Laeger; 1986 Jun; 148(25):1528-31. PubMed ID: 3529542
    [No Abstract]   [Full Text] [Related]  

  • 30. A prospective randomized study of the efficacy and cost-effectiveness of high and low dose regimens of I-131 treatment in hyperthyroidism.
    Pusuwan P; Tuntawiroon M; Sritongkul N; Chaudakshetrin P; Nopmaneejumruslers C; Komoltri C; Thepamongkhol K; Khiewvan B; Tuchinda P; Sriussadaporn S
    J Med Assoc Thai; 2011 Mar; 94(3):361-8. PubMed ID: 21560845
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Radioiodine therapy and thyrostatic drugs and iodine.
    Moka D; Dietlein M; Schicha H
    Eur J Nucl Med Mol Imaging; 2002 Aug; 29 Suppl 2():S486-91. PubMed ID: 12192550
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Hormone formation in the thyroid gland following administration of I-131].
    Aulov DM; Gokhberg SL
    Med Radiol (Mosk); 1974 May; 19(5):89-92. PubMed ID: 4848876
    [No Abstract]   [Full Text] [Related]  

  • 33. Prospective randomized comparison of intravenous versus subcutaneous administration of radioiodine for treatment of hyperthyroidism in cats.
    Théon AP; Van Vechten MK; Feldman E
    Am J Vet Res; 1994 Dec; 55(12):1734-8. PubMed ID: 7887519
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Intravenous or oral 131I treatment of hyperthyroidism and thyroid cancer?].
    Müller KD; Grebe SF; Bock FL; Müller H; Fängewisch GL
    Nuklearmedizin; 1994 Jun; 33(3):87-92. PubMed ID: 8090631
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Radioiodine treatment of hyperthyroidism in a pregnant women.
    Berg GE; Nyström EH; Jacobsson L; Lindberg S; Lindstedt RG; Mattsson S; Niklasson CA; Norén AH; Westphal OG
    J Nucl Med; 1998 Feb; 39(2):357-61. PubMed ID: 9476950
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of long-term results of two schedules of treatment for toxic multinodular goitre with radioiodine therapy (I 131).
    Khanna CM; Magdum M; Ravishankar L; Dham DN; Chugh P
    J Assoc Physicians India; 1996 Feb; 44(2):102-5. PubMed ID: 10999060
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prospective randomized clinical trial to evaluate the optimal dose of 131 I for remnant ablation in patients with differentiated thyroid carcinoma.
    Bal C; Padhy AK; Jana S; Pant GS; Basu AK
    Cancer; 1996 Jun; 77(12):2574-80. PubMed ID: 8640708
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Studies on 131-I treatment of hyperthyroidism. 4. Effect of x-ray and 131-I irradiation on cultured human thyroid cells].
    Konishi J
    Naika Hokan; 1970 Nov; 17(11):403-13. PubMed ID: 5530465
    [No Abstract]   [Full Text] [Related]  

  • 39. Incidence of radiation thyroiditis and thyroid remnant ablation success rates following 1110 MBq (30 mCi) and 3700 MBq (100 mCi) post-surgical 131I ablation therapy for differentiated thyroid carcinoma.
    Cherk MH; Kalff V; Yap KS; Bailey M; Topliss D; Kelly MJ
    Clin Endocrinol (Oxf); 2008 Dec; 69(6):957-62. PubMed ID: 18419785
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Changes in thyroid volume after radioactive iodine therapy in patients with single toxic thyroid nodule].
    Gołkowski F; Jabrocka-Hybel A; Huszno B
    Przegl Lek; 2005; 62(5):284-6. PubMed ID: 16334533
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.